Radiopharmaceuticals Based on Ligands to Gastrin-Releasing Peptide Receptors: Current State of the Issue and Russian Developments

Data are presented on ligands based on bombesin derivatives, which are peptides that specifically bind to gastrin-releasing factor receptors, that are promising for use in nuclear medicine. An analysis of developments related to the creation of radiopharmaceuticals (RPs) based on gastrin-releasing p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanobiotechnology Reports (Online) 2023-08, Vol.18 (4), p.643-649
Hauptverfasser: Maystrenko, D. N., Stanzhevsky, A. A., Sergunova, K. A., Shatik, S. V., Antuganov, D. O., Sysoev, D. S., Nadporozhsky, M. S., Konevega, A. L., Trashkov, A. P., Molchanov, O. E., Maksimov, V. I., Chipiga, L. A., Vodovatov, A. V., Popova, A. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Data are presented on ligands based on bombesin derivatives, which are peptides that specifically bind to gastrin-releasing factor receptors, that are promising for use in nuclear medicine. An analysis of developments related to the creation of radiopharmaceuticals (RPs) based on gastrin-releasing peptide-receptor agonists for radionuclide diagnostics and systemic radiation therapy is carried out. The stages of pharmaceutical development of the first Russian RPs 68 Ga-NOTA-AMBA and 177 Lu-DOTA-AMBA are described, including the synthesis technology using automated modules, as well as drug specifications.
ISSN:2635-1676
1995-0780
2635-1684
1995-0799
DOI:10.1134/S2635167623600177